(Q28196818)
Statements
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease (English)
0 references
29 July 2003
0 references
108
0 references
4
0 references
399-406
0 references